The 20 Best Prostate Cancer Doctors Near Me in Glen Burnie, MD

Dr. Michael A. Carducci is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine. He serves as the Vice Chair of Solid Tumor Oncology in the Department of Oncology. Dr. Carducci has an expertise in various types of cancer including prostate, kidney, and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology. A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital. He was promoted to Professor of Oncology and Urology in 2008 and installed into the inaugural AEGON Professorship in Prostate Cancer Research in 2009. He served as Co-Director of the GU Oncology program until 2013. In 2013, he assumed the leadership role of Associate Director for Clinical Research until being named Vice-Chair of Solid Tumor Oncology in 2024. A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He chaired the Genitourinary Oncology Committee of ECOG-ACRIN from 2011-2024. In this role, he served on the GU Steering Committee for the NCI. Dr. Carducci is a member of the Investigational Drug Steering Committee for the NCI, and chaired that Committee for four years. He served as Associate Editor for GU Cancers for the Journal of Clinical Oncology from 2013-2024. Overall, his clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Carducci is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Carducci is board certified in American Board Of Internal Medicine.

Dr. Kenneth Pienta is the Donald S. Coffey Professor of Urology and a professor of oncology at the Johns Hopkins School of Medicine. He also holds an appointment in the department of pharmacology and molecular sciences. He is an internationally recognized leader in prostate cancer research and translational science. Dr. Pienta serves as the director of research for the Brady Urological Institute and co-leader of the Kimmel Cancer Center's Prostate Cancer Program. Dr. Pienta has a proven, peer-reviewed track record in organizing and administering a translational research program that successfully incorporates bench research, agent development and clinical application. He has international expertise in the development of novel chemotherapeutic programs for prostate cancer and has championed the concept that translational research is often best accomplished by multi-disciplinary teams of scientists and clinicians. Under his direction, the success of these endeavors led to the receipt of the first annual American Association for Cancer Research Team Science Award in 2007. Dr. Pienta received his B.A. in human biology from the Johns Hopkins University. He earned his M.D. from the Johns Hopkins School of Medicine. He completed his residency at the University of Chicago Hospitals and Clinics and performed a fellowship in oncology at The Johns Hopkins Hospital. Prior to joining Johns Hopkins, Dr. Pienta was the associate vice president for research, health sciences for the University of the Michigan from 2012 to 2013 and director of precision medicine for the Michigan Center for Translational Pathology from 2008 to 2013. He joined the Johns Hopkins faculty in 2013. Dr. Pienta's research interests include the ecology of cancer, tumor microenvironment, metastasis, biomarker development and novel therapeutic development. Dr. Pienta is a two-time American Cancer Society Clinical Research Professor Award recipient. He holds several patents, has authored more than 350 peer-reviewed articles and has been the principle investigator on numerous local and national clinical trials. Dr. Pienta is currently actively developing clinical trials and treating patients with newly diagnosed high risk and metastatic prostate cancer. Dr. Pienta is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bone Tumor, Familial Prostate Cancer, Prostatectomy, and Orchiectomy. Dr. Pienta is board certified in American Board Of Internal Medicine.

Dr. Christian Pavlovich is Bernard L. Schwartz Distinguished Professor in Urologic Oncology at the Johns Hopkins University School of Medicine and Director of the Prostate Cancer Active Surveillance Program at the Brady Urological Institute. Dr. Pavlovich treats cancer with an emphasis on minimizing morbidity and maximizing quality of life while offering patients the latest treatment options and techniques. His clinical focus is on prostate and kidney cancer, and on clinical trials regarding detection, surveillance, and immunotherapy. With more than 20 years of experience with minimally-invasive surgery for the treatment of urologic cancers, he is expert in robotic surgery and was named one of the top prostate cancer surgeons in the United States by Newsweek in 2024. In addition, he offers patients modern diagnostic biopsy techniques, and for prostate cancer patients active surveillance and ablative options including cryotherapy and TULSA. Dr. Pavlovich grew up in Washington DC, went to Harvard University, and then earned his medical degree at the University of California, San Francisco (UCSF) School of Medicine. He then completed a urology residency at New York Hospital-Cornell Medical Center and a National Cancer Institute SUO fellowship in urologic oncology before joining the Hopkins faculty in 2001. Dr. Pavlovich has published over 150 peer-reviewed articles, is Associate Editor of The Prostate and is on the Editorial Board of the British Journal of Urology International. He was the inaugural Director of the Brady Urological Institute’s SUO Urologic Oncology Fellowship (2014 -2024) and is the recipient of three “best teaching/research mentor” awards from the Urology residents at Johns Hopkins. Dr. Pavlovich speaks English, French, Spanish, German, and Serbo-Croatian. He enjoys spending time with his wife and children, following their pursuits, and skiing, diving, running, wildlife, and the great outdoors. Dr. Pavlovich is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Pavlovich is board certified in American Board Of Urology.

Dr. Misop Han is David Hall McConnell Professor of Urology and Oncology at the Johns Hopkins School of Medicine. Dr. Han is a urologist whose main clinical focus is in urological oncology with a special emphasis on prostate and kidney cancers. He specializes in robotic nerve-sparing prostatectomy and robotic nephrectomy. Dr. Han received his undergraduate and medical degrees at Johns Hopkins. After an internship in surgery and residency in urology, also at Johns Hopkins, he worked as faculty at Northwestern University and Hospital in Chicago, Illinois. In 2006, he joined the Johns Hopkins faculty. His research interests include the outcome of radical prostatectomy, medical robotics and prediction modeling (what happens to men following surgery for prostate cancer). He has published extensively in these subjects and has received international and national recognition for his research. He is actively involved in several clinical research projects with the database of more than 20,000 men who received surgery for prostate cancer at The Johns Hopkins Hospital. He is a member of the American Urological Association and the American Medical Association. Dr. Han is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Ureterocele, Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Han is board certified in American Board Of Urology.

Dr. Samuel Denmeade is the R. Dale Hughes Professor of Oncology and Urology at the Johns Hopkins University School of Medicine and Director of the Genitourinary Oncology Division for the Johns Hopkins Kimmel Cancer Center. He also has appointments in the Department of Pharmacology and Molecular Sciences and Department of Biomolecular Engineering. His areas of clinical expertise include bladder cancer, kidney cancer, prostate cancer and testicular cancer. Dr. Denmeade earned his M.D. from the Columbia College of Physicians and Surgeons of Columbia University. He completed his residency at the University of Chicago. He performed a fellowship in oncology at The Johns Hopkins Hospital and a fellowship in medical oncology at the Johns Hopkins University School of Medicine. His research interests include prostate cancer, bipolar androgen therapy, clinical trials and targeted drug development. Dr. Denmeade has published over 200 papers in the area of prostate cancer research. He has received extensive funding from the NIH, the Department of Defense Prostate Cancer Research Fund and the Prostate Cancer Foundation. He is the Editor-in-Chief of the medical journal The Prostate. Dr. Denmeade is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Denmeade is board certified in American Board Of Internal Medicine.

Vladimir Kakitelashvili is a Urologist practicing medicine in Glen Burnie, Maryland. Dr. Kakitelashvili is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Orchitis, Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Prostatectomy.

Phuoc Tran is a Radiation Oncologist practicing medicine in Baltimore, Maryland. Dr. Tran is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Lung Cancer, Prostatectomy, and Pancreaticoduodenectomy.

Mohummad Siddiqui is a Urologist practicing medicine in Baltimore, Maryland. Dr. Siddiqui is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, Vasectomy, and Nephrectomy.

Mario Eisenberger is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Eisenberger is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Chromophobe Renal Cell Carcinoma, Hormone Replacement Therapy (HRT), and Prostatectomy.

Herbert Carter is a Urologist practicing medicine in Baltimore, Maryland. Dr. Carter is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Hydrocele, Prostatectomy, and Vasectomy.

Theodore DeWeese is The Frances Watt Baker, M.D., and Lenox D. Baker Jr., M.D. Dean of the Medical Faculty and CEO, Johns Hopkins Medicine. Dr. DeWeese is professor of oncology and urology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include prostate cancer, radiation oncology and urological oncology. He and his colleagues focus their research on developing new ways to enhance radiation-induced killing of prostate cancer cells. This includes development of novel, prostate cancer-targeted RNA molecules as well as new ways to modulate androgen receptor signaling. He and his colleagues also developed the first adenoviral gene therapy trial for prostate cancer, using a common cold virus to target cancer cells while leaving normal cells unharmed. Dr. DeWeese earned his M.D. from the University of Colorado Health Sciences Center. He completed his residency at The Johns Hopkins Hospital, serving as chief resident, and performed a laboratory research fellowship at the Johns Hopkins Oncology Center and the James Buchanan Brady Urological Institute. Dr. DeWeese's research interests include prostate cancer, DNA damage, and radiation sensitization. Dr. DeWeese has served on numerous committees and boards including as President and Chair of the Board for the American Society for Radiation Oncology. He also serves on committees for the American Association for Cancer Research and was appointed by the National Academy of Sciences as a scientific counselor for the Radiation Effects Research Foundation in Hiroshima, Japan. He has received numerous awards and honors, including several teaching awards from Johns Hopkins. Make A Gift. Dr. Deweese is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bone Tumor, Prostatectomy, and Orchiectomy. Dr. Deweese is board certified in American Board Of Radiology.

Dr. Ana Kiess's clinical focus is on the treatment of prostate cancer and head and neck cancers with external beam radiotherapy and radiopharmaceutical therapies. Her research concentrates on the integration of new radiopharmaceutical therapies and dosimetry techniques into the clinic. Dr. Kiess received her bachelors of science degree in chemical engineering from the University of Virginia, after which she obtained a doctorate of medicine and a doctorate of philosophy degree in biomedical engineering from Duke University. Following medical school, she matriculated to the resident staff at Memorial Sloan Kettering Cancer Center, receiving extensive oncologic training and research experience. She also completed a postdoctoral research fellowship at Johns Hopkins University in the Department of Radiology. Make A Gift. Dr. Kiess is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Laryngeal Cancer, Acinic Cell Carcinoma of Salivary Glands, Gastrostomy, and Adenoidectomy. Dr. Kiess is board certified in American Board Of Radiology.

Dr. Daniel (Danny) Song is a Professor of Radiation Oncology, with joint appointments in Urology and Oncology. He serves as the Co-director of the Prostate Cancer Multidisciplinary Clinic at the Johns Hopkins Hospital and the Physician Advisor and Director of Faculty Affairs for the Department of Radiation Oncology and Molecular Radiation Sciences. His area of clinical expertise is in the management of genitourinary cancers, including cancers of the prostate, bladder and urinary tract, and testicular cancer. Dr. Song applies his expertise and clinical experience in the utilization of a variety of radiation modalities including external beam radiation, image-guided and intensity-modulated radiation, prostate brachytherapy (seed implants), and stereotactic body radiation therapy. Dr. Song's research interests include the development and refinement of new imaging methods to improve radiation targeting, as well as innovative means of reducing potential side effects of radiation treatment. His research is supported by federal and private research funding programs including two R01 awards from the National Cancer Institute, Department of Defense Prostate Cancer Clinical Trial Award, the American Cancer Society, and the Hopkins-BMS Immuno-Oncology Consortium. He is a reviewer and examiner for the American Board of Radiology, which administers the national board certification examination for radiation oncologists. He has served on the editorial boards of the International Journal of Radiation Oncology, Biology, Physics and The Prostate, and on the scientific review committees for the American Society for Radiation Oncology (ASTRO), American Brachytherapy Society, and the Dept of Defense Prostate Cancer Research Program. He currently serves on the Scientific Planning Committee for the American Brachytherapy Society annual meeting. He has co-authored consensus guidelines on stereotactic body radiation therapy (TG-101) and image-guided robotic brachytherapy (TG-192) produced by the American Association of Physics in Medicine. Dr. Song sees patients at the Johns Hopkins Hospital (downtown Baltimore) as well as Greenspring Station (Timonium) practices. Make A Gift. Dr. Song is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer. Dr. Song is board certified in American Board Of Radiology.

Arthur Burnett is a Urologist practicing medicine in Baltimore, Maryland. Dr. Burnett is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Priapism, Erectile Dysfunction (ED), Peyronie Disease, Prostatectomy, and Penectomy. Dr. Burnett is board certified in American Board Of Urology.

Jiakai Zhu is a Urologist practicing medicine in Glen Burnie, Maryland. Dr. Zhu is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Prostate Cancer, Urinary Tract Infection in Children, and Ureteroscopy.

David Mcdermott is a Urologist practicing medicine in Glen Burnie, Maryland. Dr. Mcdermott is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Congenital Mesoblastic Nephroma, Urothelial Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Akshar Patel is a Radiation Oncologist practicing medicine in Glen Burnie, Maryland. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC).

Min Oh is a Radiation Oncologist practicing medicine in Glen Burnie, Maryland. Dr. Oh is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Pleuropulmonary Blastoma, Angiosarcoma, and Gamma Knife Radiosurgery.

Rian Dickstein is a Urologist practicing medicine in Hanover, Maryland. Dr. Dickstein is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Hydronephrosis, Ureteroscopy, and Nephrectomy.

Jason Molitoris is a Radiologist and a Radiation Oncologist practicing medicine in Baltimore, Maryland. Dr. Molitoris is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Adult Soft Tissue Sarcoma, Familial Prostate Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Molitoris is board certified in American Board Of Radiology.